Optical Coherence Tomography for blood glucose monitoring through signal attenuation

dc.contributor.authorPRETTO, LUCAS R. de
dc.contributor.authorYOSHIMURA, TANIA M.
dc.contributor.authorRIBEIRO, MARTHA S.
dc.contributor.authorFREITAS, ANDERSON Z. de
dc.contributor.editorIZATT, JOSEPH A.
dc.contributor.editorFUJIMOTO, JAMES G.
dc.contributor.editorTUCHIN, VALERY V.
dc.coverageInternacionalpt_BR
dc.creator.eventoOPTICAL COHERENCE TOMOGRAPHY AND COHERENCE DOMAIN OPTICAL METHODS IN BIOMEDICINE, 20thpt_BR
dc.date.accessioned2017-03-07T12:58:37Z
dc.date.available2017-03-07T12:58:37Z
dc.date.eventoFebruary 13, 2016
dc.description.abstractDevelopment of non-invasive techniques for glucose monitoring is crucial to improve glucose control and treatment adherence in patients with diabetes. Hereafter, Optical Coherence Tomography (OCT) may offer a good alternative for portable glucometers, since it uses light to probe samples. Changes in the object of interest can alter the intensity of light returning from the sample and, through it, one can estimate the sample's attenuation coefficient (μt) of light. In this work, we aimed to explore the behavior of μt of mouse’s blood under increasing glucose concentrations. Different samples were prepared in four glucose concentrations using a mixture of heparinized blood, phosphate buffer saline and glucose. Blood glucose concentrations were measured with a blood glucometer, for reference. We have also prepared other samples diluting the blood in isotonic saline solution to check the effect of a higher multiple-scattering component on the ability of the technique to differentiate glucose levels based on μt. The OCT system used was a commercial Spectral Radar OCT with 930 nm central wavelength and spectral bandwidth (FWHM) of 100 nm. The system proved to be sensitive for all blood glucose concentrations tested, with good correlations with the obtained attenuation coefficients. A linear tendency was observed, with an increase in attenuation with higher values of glucose. Statistical difference was observed between all groups (p<0.001). This work opens the possibility towards a non-invasive diagnostic modality using OCT for glycemic control, which eliminates the use of analytes and/or test strips, as in the case with commercially available glucometers.pt_BR
dc.event.siglaSPIEpt_BR
dc.format.extent96973F-1 - 96973F-9pt_BR
dc.identifier.citationPRETTO, LUCAS R. de; YOSHIMURA, TANIA M.; RIBEIRO, MARTHA S.; FREITAS, ANDERSON Z. de. Optical Coherence Tomography for blood glucose monitoring through signal attenuation. In: IZATT, JOSEPH A. (ed.); FUJIMOTO, JAMES G. (ed.); TUCHIN, VALERY V. (ed.). In: OPTICAL COHERENCE TOMOGRAPHY AND COHERENCE DOMAIN OPTICAL METHODS IN BIOMEDICINE, 20th, February 13, 2016, San Francisco, California, USA. <b>Proceedings...</b> p. 96973F-1 - 96973F-9. (SPIE Proceedings Series, 9697). DOI: <a href="https://dx.doi.org/10.1117/12.2213347">10.1117/12.2213347</a>. Disponível em: http://repositorio.ipen.br/handle/123456789/27115.
dc.identifier.doi10.1117/12.2213347
dc.identifier.orcidhttps://orcid.org/0000-0002-5018-9126
dc.identifier.orcidhttps://orcid.org/0000-0002-4203-1134
dc.identifier.urihttp://repositorio.ipen.br/handle/123456789/27115
dc.local.eventoSan Francisco, California, USApt_BR
dc.publisherBellingham, Washington USA: Society of Photo-optical Instrumentation Engineerspt_BR
dc.relation.ispartofseriesSPIE Proceedings Series, 9697pt_BR
dc.rightsopenAccesspt_BR
dc.subjecttomography
dc.subjectoptical systems
dc.subjectcoherence length
dc.subjectattenuation
dc.subjectin vitro
dc.subjectdiabetes mellitus
dc.subjecthyperglycemia
dc.subjectblood
dc.subjectglucose
dc.subjectmonitoring
dc.titleOptical Coherence Tomography for blood glucose monitoring through signal attenuationpt_BR
dc.typeTexto completo de eventopt_BR
dspace.entity.typePublication
ipen.autorANDERSON ZANARDI DE FREITAS
ipen.autorMARTHA SIMOES RIBEIRO
ipen.autorTANIA MATEUS YOSHIMURA
ipen.autorLUCAS RAMOS DE PRETTO
ipen.codigoautor880
ipen.codigoautor574
ipen.codigoautor10230
ipen.codigoautor11268
ipen.contributor.ipenauthorANDERSON ZANARDI DE FREITAS
ipen.contributor.ipenauthorMARTHA SIMOES RIBEIRO
ipen.contributor.ipenauthorTANIA MATEUS YOSHIMURA
ipen.contributor.ipenauthorLUCAS RAMOS DE PRETTO
ipen.date.recebimento17-03pt_BR
ipen.event.datapadronizada2016pt_BR
ipen.identifier.ipendoc22984pt_BR
ipen.identifier.ods3
ipen.notas.internasProceedingspt_BR
ipen.type.genreArtigo
relation.isAuthorOfPublicationa8d821f0-a0a4-4d52-b582-5c5d0afce8f5
relation.isAuthorOfPublication36215a53-0150-4910-91d7-9559717b62d7
relation.isAuthorOfPublication36384aec-6adf-42ef-99ae-68f62b9a69b9
relation.isAuthorOfPublication64a32d36-2971-45c5-a8a3-c266b2ed3e42
relation.isAuthorOfPublication.latestForDiscovery64a32d36-2971-45c5-a8a3-c266b2ed3e42
sigepi.autor.atividadePRETTO, LUCAS R. DE:11268:920:Spt_BR
sigepi.autor.atividadeYOSHIMURA, TANIA M.:10230:920:Npt_BR
sigepi.autor.atividadeRIBEIRO, MARTHA S.:574:920:Npt_BR
sigepi.autor.atividadeFREITAS, ANDERSON Z. DE:880:920:Npt_BR

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
22984.pdf
Tamanho:
653.81 KB
Formato:
Adobe Portable Document Format
Descrição:

Licença do Pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:

Coleções